Showing results (621-630 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndromeM Johansson, L CarlssonJournal of Cardiovascular Pharmacology and Therapeutics|October 7, 2010
Clinical and economic impact of clinical pharmacy service on hyperlipidemic management in Hong KongJennifer S T Chung, Kenneth K C Lee, Brian Tomlinson, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 22, 2014
Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of AtherosclerosisJian Li, Qiuwang Zhang, Dan Li, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 21, 2016
Knockout of the Prostaglandin E2 Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in MiceShuang Liu, Yawei Ji, Jian Yao, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 23, 2013
Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysisHemang B Panchal, Tejaskumar Shah, Parthavkumar Patel, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 26, 2014
Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized TrialMohammad Reza Dehghani, Majid Kasianzadeh, Yousef Rezaei, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 26, 2015
Hypothesis: Metalloproteinase Inhibitors Decrease Risks of Cardiovascular DiseaseMichelle Lizotte-Waniewski, Keith Brew, Charles H HennekensJournal of Cardiovascular Pharmacology and Therapeutics|January 30, 2016
Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction RatsDandan Wang, Tao Liu, Shaobo Shi, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 10, 2016
Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of ActionHong Jiang, David J Polhemus, Kazi N Islam, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2016
Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled TrialsSandip Chaugai, Wen Yeng Meng, Amir Ali SepehryPageof 129